Loading company…
Riskpilot
← Back to search
Sign in
Get full access
TID & SYN AS
AS
Active
Org 961586763
Sentrumsvegen 55, 4700 Vennesla
Retail sale of medical and orthopaedic goods · NACE 4774
Est. 1991
10 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 8,2M
-3% vs 2023
EBITDA margin
1.9%
-83% vs 2023
Equity ratio
58.5%
Financial strength
Net profit 2024
NOK 114K
-84% vs 2023
EBITDA — year on year
NOK millions
1M
1M
0M
-1M
-1M
0M
2020
0M
0%
2021
-1M
-100%
2022
1M
+200%
2023
0M
-100%
2024
Key figures
Annual report 2024
Revenue
NOK 8,2M
-3%
EBITDA
NOK 157K
-83%
Net profit
NOK 114K
-84%
Total assets
NOK 3,1M
-7%
Equity
NOK 1,8M
-2%
Employees
10
—
Company information
Legal name
TID & SYN AS
Org number
961586763
Legal form
Aksjeselskap
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
10. juni 1991
Share capital
NOK 34 000
Employees
10 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Contact
Address
Sentrumsvegen 55, 4700 Vennesla
Phone
+4738155870
Email
post@tidogsyn.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Retail sale of medical and orthopaedic goods
Companies in Vennesla
All Norway companies
Revenue
NOK millions
0M
3M
5M
8M
10M
8M
2020
9M
2021
8M
2022
8M
2023
8M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
-1M
2022
1M
2023
0M
2024
Income statement
NOK thousands
Item
2020
2021
2022
2023
2024
Revenue
8 089
8 675
8 011
8 452
8 222
Staff expenses
−3 254
−3 760
−3 272
−2 322
−3 087
EBITDA
68
−75
−529
939
157
Depreciation & amort.
−41
−50
−51
−36
−36
EBIT
27
−125
−579
904
122
Net financials
18
5
41
16
23
Profit before tax
45
−120
−539
920
144
Tax
8
−26
−117
198
30
Net profit
37
−93
−422
722
114
Balance sheet
NOK thousands
Item
2020
2021
2022
2023
2024
Total assets
4 930
5 104
4 668
3 325
3 107
Equity
3 646
3 552
3 131
1 853
1 817
Long-term debt
0
0
0
0
150
Short-term debt
1 284
1 552
1 538
1 472
1 140
Total debt
1 284
1 552
1 538
1 472
1 290
Financial ratios
5-year trend
EBITDA margin
1.9%
This company
15.8%
Market median
-88% vs market
2020
2024
Equity ratio
58.5%
This company
38.2%
Market median
+53% vs market
2020
2024
Return on equity
6.3%
This company
18.4%
Market median
-66% vs market
2020
2024
Net profit margin
1.4%
This company
8.1%
Market median
-83% vs market
2020
2024
Asset turnover
2.65×
This company
1.12×
Market median
+137% vs market
2020
2024
Debt / equity
0.71×
This company
0.62×
Market median
+15% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
KJ
Kåre Jarl Lundevold
Chief Executive Officer
Chief Executive Officer
2025
Former (1)
TP
Tove Premak
Chief Executive Officer
Chief Executive Officer
2003 – 2023
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
JG
Jostein Gundersen
Board of Directors
2023
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Unknown
Individual
33.33%
33.33%
2022
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of TID & SYN AS also hold positions in
0
other companies.
Person
Role here
Other companies
Kåre Jarl Lundevold
Chief Executive Officer
0 companies
Tove Premak
Chief Executive Officer
0 companies
Jostein Gundersen
Board of Directors
0 companies